- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid Malignancies
Total 7147 results
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Beijing Mabworks Biotech Co., Ltd.Recruiting
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
University Medical Center GroningenTerminatedMetastatic MalignanciesNetherlands
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Clover Biopharmaceuticals AUS Pty LtdCompletedPeritoneal MalignanciesAustralia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced MalignanciesJapan
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Southwest Hospital, ChinaUnknown
-
Infinity Pharmaceuticals, Inc.Terminated
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
Shanghai Tongji Hospital, Tongji University School...Recruiting
-
University of PittsburghAmerican College of Radiation OncologyNot yet recruitingUpper Abdominal MalignanciesUnited States
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Novartis PharmaceuticalsActive, not recruitingALK Positive MalignanciesChina, United States, Italy, Taiwan, Australia, Belgium, Germany, Spain, Czechia, Japan, Russian Federation, Korea, Republic of, Hong Kong, France, Lebanon, Malaysia, Brazil, Poland, Bulgaria, Colombia, Singapore
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
InnoCare Pharma Inc.Not yet recruiting
-
Shanghai Escugen Biotechnology Co., LtdRecruitingB-cell Lymphoid MalignanciesChina
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
MedImmune LLCCompletedCancer | B-cell MalignanciesUnited States, Italy, Belgium, Canada, Spain
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Cooperative Study Group A for HematologyCompletedHEMATOLOGIC MALIGNANCIESKorea, Republic of
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | MyelosuppressionRussian Federation
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
First Affiliated Hospital of Fujian Medical UniversityRecruitingBiliary Tract MalignanciesChina
-
BeiGeneRecruitingB-cell MalignanciesChina, Italy, United States, Spain, United Kingdom, Poland, Czechia, Netherlands, Greece, France, Sweden, Korea, Republic of, Turkey
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnHistologically-confirmed MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
Nantes University HospitalFor Ever FabienRecruitingChild, Only | Hematologic Malignancy | Hematologic Non Malignancy | Solid Tumor, ChildhoodFrance
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States, Canada
-
Assistance Publique - Hôpitaux de ParisRecruitingSolid Tumor | Thoracic Cancer | Hematologic Malignancy | Cancer, Treatment-Related | Vaccine Response ImpairedFrance
-
Fondazione EMN Italy OnlusCompletedHEMATOLOGIC MALIGNANCIESItaly
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
Sinocelltech Ltd.RecruitingRelapsed or Refractory Hematologic MalignanciesChina
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
Shanghai Escugen Biotechnology Co., LtdEscugen (Australia) Biotechnology Pty LtdNot yet recruitingB-cell Lymphoid Malignancies